Gliptins and Cardiovascular Outcomes: A Comparative and Critical Analysis after TECOS

Table 3

Baseline characteristics [6].

Age	57 years or less
Sex	Predominantly males
Average HBA1C	8.2%
Active comparators	(i) Placebo; (ii) Metformin; (iii) Sulfonylureas; (iv) Insulin